Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study

Seasonal influenza causes substantial morbidity and mortality in China, which largely results from limited vaccine accessibility and poor vaccination coverage. Since 2013, Sanofi Pasteur’s facilities in Shenzhen, China have produced a trivalent inactivated influenza vaccine (Shz-IIV3) for each influ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Hu, Yuemei, Chu, Kai, Lavis, Nathalie, Li, Xiaoling, Liang, Bill, Liu, Shuzhen, Shao, Ming, Shu, Jean-Denis, Tabar, Cynthia, Samson, Sandrine
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6605815/
https://ncbi.nlm.nih.gov/pubmed/30779689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1581541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados